Patient Information for Surgery in Primary and Secondary Hyperparathyroidism




© Springer-Verlag Italia 2016
Guido Gasparri, Nicola Palestini and Michele Camandona (eds.)Primary, Secondary and Tertiary HyperparathyroidismUpdates in Surgery10.1007/978-88-470-5758-6_19


19. Patient Information for Surgery in Primary and Secondary Hyperparathyroidism



Pier Giorgio Nasi and Lodovico Rosato 


(1)
Department of Surgery, ASL4, Ivrea Hospital, Ivrea, Italy

 



 

Lodovico Rosato



Parathyroid surgery can have some complications. These are mainly: lesions of recurrent nerves, definitive hypocalcemia, and persistent or recurrent hyperparathyroidism.

The surgeon has a duty to adequately inform the patient regarding: the indications for surgical treatment; possible alternative treatments; the advantages expected from surgical intervention; possible risks (both general, specific complications); possible clinical conditions in the event of permanent postoperative lesions; the required conduct during treatment and convalescence; possible implications in the event of pregnancy in women of reproductive age.

The information should be provided promptly in a simple, clear, complete and comprehensive form [1]. The surgeon will request consent to carry out the surgery only after providing the most complete information, taking into particular consideration any expression of disagreement at all, either on specific aspects of the procedure or on their possible consequences.

It is useful and strongly advisable that this informed consent should be in written format, and even more so in the event of any disagreement or reservation, given the particular characteristics of the treatment (partial or total removal of the parathyroid) and the possible consequences for the total physical wellbeing of the patient. The received consent should be specifically documented in the patient’s medical record.

The Italian Association of Endocrine Surgery Units (U.E.C. CLUB) suggest two consensus forms in parathyroid surgery for primary (Box 19.1) and secondary hyperparathyroidism (Box 19.2), which must be personalized and signed by the patient and the surgeon [2].

BOX 19.1

PRIMARY HYPERPARATHYROIDISM INFORMED CONSENT FORM

I, the undersigned, ……………………………… declare having been informed in a clear and understandable manner by Dr ………………………….., both at initial visit and at admission, that the condition I was diagnosed with, i.e. Primary Hyperparathyroidism, requires surgical intervention. The scope, benefits (also relative to alternative treatments), possible risks and/or foreseeable injuries have been clearly explained to me. It has been explained to me that, if ultrasound and/or scintigraphic findings are confirmed intraoperatively, the scheduled surgery will consist of removal of the diseased gland or glands, or of subtotal or total removal of parathyroid glands in the event that all glands are affected.

I have been informed that this procedure may involve:

May 31, 2017 | Posted by in ENDOCRINOLOGY | Comments Off on Patient Information for Surgery in Primary and Secondary Hyperparathyroidism

Full access? Get Clinical Tree

Get Clinical Tree app for offline access